Questions across 2 calls

Sudarshan Padmanabhan

ASK

Acutaas Chemicals Limited

Acutaas Chemicals Limited CC-Feb26.pdf · 2026-01-28

Yes. Thank you for taking my question. Actually, taking forward from the previous participant, I mean, now two things. One is we know that the oncology product itself is doing well. If we go by Orion's commentary this year and also there is a lot of product life cycle extension happening. So if I look at 3 years when you're talking about the INR1,000 crores target, how is the contribution from non -oncology products going to be? So if you can give some color on the dependency of oncology and how are the other products in the pipeline?

Sure. And sir, then coming to the electrolyte business that is on the battery chemical side. Now we are looking at vinyl carbonate and fluoroethylene carbonate, a couple of products. But if I take 2, 3 years down the line, are we looking to expand this basket? I mean, what is the strategy here in terms of growing the booking of product?

Sumitomo Chemical India Limited

Sumitomo Chemical India Limited CC-Nov25.pdf · 2025-10-28

Sir, my question is on the -- your earlier comment on the international business, where you said that after a long period of time, you're seeing some light at the end of the tunnel. In this space, I mean, we have been doing a lot of -- talking about exports, while it has not scaled up to the extent that we had initially thought. But in terms of the profitability and the outlook of this segment of the business, I mean, how is it currently stacking as compared to what it was, say, 2, 3 years ago when we were actually talking about being a serious player in terms of the value chain of our group?

Sure. But clearly, it looks like the race to the bottom of the price is for the time being largely done, because that is something that we've been seeing for last few years.